http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102406615-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102406615-B |
| titleOfInvention | The former times how sour salmaterol chitosan nanoparticle preparation that a kind of wheat germ agglutinin is modified |
| abstract | The present invention relates to medical art, is the former times how sour salmaterol chitosan nanoparticle preparation and preparation method thereof that a kind of wheat germ agglutinin is modified.The present invention adopts ionic cross-linking to prepare former times how sour salmaterol chitosan nano; And utilize alveolar epithelium to there is the feature of specific sugar receptor N-Acetyl-D-glucosamine, make the former times how sour salmaterol chitosan nano that wheat germ agglutinin is modified, to be combined by the specific sugar receptor N-Acetyl-D-glucosamine of wheat germ agglutinin with alveolar epithelium, make former times how sour salmaterol chitosan nano have guiding alveolar membrane targeting.External sugared binding tests result shows, the former times how sour salmaterol chitosan nano that wheat germ agglutinin is modified has the advantage of guiding alveolar membrane, thus can reduce dosage, reduces toxic and side effects; The valid density time that the slow release of medicine makes medicine maintain in pulmonary is long, strengthens therapeutic effect.Invention formulation can be used for the medicine preparing treatment asthma, chronic bronchitis or chronic obstructive pulmonary disease. |
| priorityDate | 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.